Company intelligence / Profile preview

Northeast Pharmaceutical Group

Shenyang, Liaoning, China

Ownership: Private
Development stage: Commercial

Overview

NEPG operates at commercial scale with a broad portfolio of over 800 pharmaceutical products including APIs and finished dosage forms. It was the first Vitamin C producer in China and remains a global leader in several product categories such as Piracetam and Fosfomycin. The company has received recognition for green manufacturing practices.[1][2] Clinical results are not directly reported due to its focus on generics/established medicines.

Therapeutic areas: GastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculesBiologicsFinished pharmaceutical preparations
Industry: Biotech

Beyond the preview

Go deeper on Northeast Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Northeast Pharmaceutical Group.

Explore the full profile